skip to main content
Refinado por: Base de dados/Biblioteca: IngentaConnect Journals remover idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

BOKEMEYER, Carsten ; BONDARENKO, Igor ; LOOS, Anja H ; ZUBEL, Angela ; KORALEWSKI, Piotr ; MAKHSON, Anatoly ; HARTMANN, Joerg T ; APARICIO, Jorge ; DE BRAUD, Filippo ; DONEA, Serban ; LUDWIG, Heinz ; SCHUCH, Gunter ; STROH, Christopher

Journal of clinical oncology, 2009-02, Vol.27 (5), p.663-671 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

2
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

SALTZ, Leonard B ; CLARKE, Stephen ; COUTURE, Felix ; SIRZEN, Florin ; CASSIDY, Jim ; DIAZ-RUBIO, Eduardo ; SCHEITHAUER, Werner ; FIGER, Arie ; WONG, Ralph ; KOSKI, Sheryl ; LICHINITSER, Mikhail ; YANG, Tsai-Shen ; RIVERA, Fernando

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2013-2019 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Texto completo disponível

3
Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

CASSIDY, Jim ; CLARKE, Stephen ; COUTURE, Felix ; SIRZEN, Florin ; SALTZ, Leonard ; DIAZ-RUBIO, Eduardo ; SCHEITHAUER, Werner ; FIGER, Arie ; WONG, Ralph ; KOSKI, Sheryl ; LICHINITSER, Mikhail ; YANG, Tsai-Shen ; RIVERA, Fernando

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2006-2012 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Texto completo disponível

4
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial

Tabernero, Josep ; Van Cutsem, Eric ; Lakomý, Radek ; Prausová, Jana ; Ruff, Paul ; van Hazel, Guy A ; Moiseyenko, Vladimir M ; Ferry, David R ; McKendrick, Joseph J ; Soussan-Lazard, Karen ; Chevalier, Soazig ; Allegra, Carmen J

European journal of cancer (1990), 2014-01, Vol.50 (2), p.320-331 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

5
Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial

Carrato, Alfredo ; Swieboda-Sadlej, Anna ; Staszewska-Skurczynska, Marzanna ; Lim, Robert ; Roman, Laslo ; Shparyk, Yaroslav ; Bondarenko, Igor ; Jonker, Derek J ; Sun, Yan ; De la Cruz, Jhony A ; Williams, J Andrew ; Korytowsky, Beata ; Christensen, James G ; Lin, Xun ; Tursi, Jennifer M ; Lechuga, Maria J ; Van Cutsem, Eric

Journal of clinical oncology, 2013-04, Vol.31 (10), p.1341-1347 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

6
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

Cohn, A.L. ; Tabernero, J. ; Maurel, J. ; Nowara, E. ; Sastre, J. ; Chuah, B.Y.S. ; Kopp, M.V. ; Sakaeva, D.D. ; Mitchell, E.P. ; Dubey, S. ; Suzuki, S. ; Hei, Y.-J. ; Galimi, F. ; McCaffery, I. ; Pan, Y. ; Loberg, R. ; Cottrell, S. ; Choo, S.-P.

Annals of oncology, 2013-07, Vol.24 (7), p.1777-1785 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Buscando em bases de dados remotas. Favor aguardar.